The most common side effects include: peripheral edema (15%), nausea (14.3%), dizziness (12.9%), fatigue (12.1%), ascites (11.4%), diarrhea (10.7%), headache (10%), muscle spasms (9.3%), itchiness (9.3%), and abdominal pain (8.6%)
PubMed laboratory research record [PMID: 16217130] PubMed record related to this compound for laboratory literature review
Provides a unique, targeted formulation that may help protect the body from oxidative damage
[PMID: 15967265] PubMed record related to this compound for laboratory literature review
As concerns FOC in LA, we noted with a cumulative addition of retatrutide a negative inotropic effect, but only at high concentrations of retatrutide (Fig
L., Dos Santos, T